Rezolute, Inc.(RZLT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RZLT Rezolute, Inc.

休市中 12-27 16:00:00 EST

4.96

-0.05

-1.00%

盘后4.96

+0.000.00%

16:35 EST

最高5.09	最低4.78	成交量29.22万
今开5.01	昨收5.01	日振幅6.17%
总市值2.87亿	流通市值2.49亿	总股本5,794万
成交额143.68万	换手率0.58%	流通股本5,027万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RZLT","market":"US","secType":"STK","nameCN":"Rezolute, Inc.","latestPrice":4.96,"timestamp":1735333200000,"preClose":5.01,"halted":0,"volume":292199,"hourTrading":{"tag":"盘后","latestPrice":4.96,"preClose":4.96,"latestTime":"16:35 EST","volume":3298,"amount":16358.0797,"timestamp":1735335321882},"delay":0,"floatShares":50267214,"shares":57943066,"eps":-1.236699,"marketStatus":"休市中","change":-0.05,"latestTime":"12-27 16:00:00 EST","open":5.01,"high":5.0899,"low":4.7808,"amount":1436766.2679986,"amplitude":0.061697,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.236699,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1735549200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":5.01,"preHourTrading":{"tag":"盘前","latestPrice":5.05,"preClose":5.01,"latestTime":"09:21 EST","volume":8410,"amount":42162.666247,"timestamp":1735309274238},"postHourTrading":{"tag":"盘后","latestPrice":4.96,"preClose":4.96,"latestTime":"16:35 EST","volume":3298,"amount":16358.0797,"timestamp":1735335321882},"volumeRatio":0.9642016636235896,"impliedVol":0.667,"impliedVolPercentile":0.234},"requestUrl":"/m/hq/s/RZLT/tweets","defaultTab":"tweets","newsList":[{"id":"2494864404","title":"Rezolute, Inc.盘中异动 早盘急速拉升5.22%报4.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494864404","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494864404?lang=zh_cn&edition=full","pubTime":"2024-12-26 23:53","pubTimestamp":1735228423,"startTime":"0","endTime":"0","summary":"北京时间2024年12月26日23时53分，Rezolute, Inc.股票出现波动，股价急速上涨5.22%。截至发稿，该股报4.64美元/股，成交量5.8382万股，换手率0.10%，振幅6.12%。Rezolute, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Scisparc Ltd.、Moolec Science Sa C/Wts 、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Scisparc Ltd.、Coeptis Therapeutics Holdings, Inc.、Hoth Therapeutics, Inc.较为活跃，换手率分别为1795.94%、404.21%、112.66%，振幅较大的相关个股有Scisparc Ltd.、Coeptis Therapeutics Holdings, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 ，振幅分别为192.72%、99.08%、94.44%。Rezolute, Inc.公司简介：Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226235343a20aa734&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226235343a20aa734&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RZLT"],"gpt_icon":0},{"id":"2492105635","title":"Rezolute, Inc.盘中异动 快速上涨6.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492105635","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492105635?lang=zh_cn&edition=full","pubTime":"2024-12-20 00:19","pubTimestamp":1734625171,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日00时19分，Rezolute, Inc.股票出现异动，股价大幅拉升6.03%。截至发稿，该股报4.33美元/股，成交量12.5597万股，换手率0.22%，振幅4.90%。Rezolute, Inc.股票所在的生物技术行业中，整体跌幅为1.64%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Psyence Biomedical Ltd.、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Psyence Biomedical Ltd.、Elevai Labs, Inc.、Phio Pharmaceuticals Corp.较为活跃，换手率分别为1397.21%、563.54%、474.86%，振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、Abpro Holdings Inc C/Wts 12/11/2029 、Psyence Biomedical Ltd.，振幅分别为172.75%、118.11%、106.54%。Rezolute, Inc.公司简介：Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122000193195ea7cc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122000193195ea7cc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"2489117285","title":"Rezolute, Inc.盘中异动 大幅下跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489117285","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489117285?lang=zh_cn&edition=full","pubTime":"2024-12-05 01:47","pubTimestamp":1733334476,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日01时47分，Rezolute, Inc.股票出现异动，股价大幅下挫5.05%。截至发稿，该股报5.08美元/股，成交量13.8398万股，换手率0.24%，振幅6.73%。Rezolute, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Cyclerion Therapeutics, Inc.、Exicure, Inc.、Heron Therapeutics, Inc.涨幅较大，Cyclerion Therapeutics, Inc.、Can Fite Biopharma Ltd、Windtree Therapeutics, Inc.较为活跃，换手率分别为3609.95%、271.89%、133.93%，振幅较大的相关个股有Cyclerion Therapeutics, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028、Apollomics Inc C/Wts 01/04/2028 ，振幅分别为237.89%、64.57%、62.02%。Rezolute, Inc.公司简介：Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205014756a1d42194&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205014756a1d42194&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"2488940963","title":"Rezolute, Inc.盘中异动 快速上涨5.49%报5.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488940963","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488940963?lang=zh_cn&edition=full","pubTime":"2024-12-04 00:17","pubTimestamp":1733242670,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日00时17分，Rezolute, Inc.股票出现异动，股价大幅上涨5.49%。截至发稿，该股报5.38美元/股，成交量23.9358万股，换手率0.41%，振幅8.59%。Rezolute, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Janux Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Nls Pharmaceutics Ltd.、Purple Biotech Ltd、Senti Biosciences, Inc.较为活跃，换手率分别为144.42%、119.42%、113.50%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Klotho Neurosciences Inc C/Wts 21/06/2029 、Coherus Biosciences, Inc.，振幅分别为69.23%、51.13%、48.91%。Rezolute, Inc.公司简介：Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204001750a269ca8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204001750a269ca8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"2488893670","title":"Rezolute, Inc.盘中异动 急速上涨5.25%报5.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488893670","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488893670?lang=zh_cn&edition=full","pubTime":"2024-12-02 23:09","pubTimestamp":1733152140,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日23时09分，Rezolute, Inc.股票出现波动，股价大幅上涨5.25%。截至发稿，该股报5.30美元/股，成交量6.0291万股，换手率0.10%，振幅3.77%。Rezolute, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。其相关个股中，Senti Biosciences, Inc.、Cingulate Inc C/Wts 10/12/2026 、Purple Biotech Ltd涨幅较大，Senti Biosciences, Inc.、Purple Biotech Ltd、Revelation Biosciences, Inc.较为活跃，换手率分别为1366.57%、1163.52%、219.82%，振幅较大的相关个股有Senti Biosciences, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Purple Biotech Ltd，振幅分别为344.44%、64.17%、50.97%。Rezolute, Inc.公司简介：Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202230900a266adaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202230900a266adaa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"2484667444","title":"Rezolute, Inc.盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484667444","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484667444?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:12","pubTimestamp":1731942733,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时12分，Rezolute, Inc.股票出现波动，股价大幅下跌5.10%。截至发稿，该股报5.02美元/股，成交量5.4141万股，换手率0.09%，振幅8.32%。Rezolute, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。其相关个股中，Hcw Biologics Inc.、Apollomics Inc C/Wts 01/04/2028 、冠科美博涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为554.95%、505.73%、337.36%，振幅较大的相关个股有Hcw Biologics Inc.、冠科美博、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为118.81%、75.18%、73.24%。Rezolute, Inc.公司简介：Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118231213a2433e38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118231213a2433e38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RZLT"],"gpt_icon":0},{"id":"2482485199","title":"Rezolute Inc  预计每股亏损 34 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482485199","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482485199?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:02","pubTimestamp":1731081758,"startTime":"0","endTime":"0","summary":"Rezolute Inc  预计每股亏损 34 美分 - 财报前瞻Rezolute Inc RZLT.OQ RZLT.O预计在公布截至2024年12月31日的财报时，季度收入将保持不变。华尔街对 Rezolute Inc 的 12 个月目标价中位数为 13.00 美元，高于其上次收盘价 5.72 美元。11月8日 - 以前季度业绩。除非另有说明，否则所有数据均以美元为单位。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4T3MF1UP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RZLT"],"gpt_icon":0},{"id":"2481693673","title":"Rezolute, Inc.盘中异动 股价大涨5.33%报5.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481693673","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481693673?lang=zh_cn&edition=full","pubTime":"2024-11-07 01:33","pubTimestamp":1730914432,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日01时33分，Rezolute, Inc.股票出现波动，股价急速拉升5.33%。截至发稿，该股报5.73美元/股，成交量12.5507万股，换手率0.22%，振幅5.51%。Rezolute, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Cardio Diagnostics Holdings Inc.涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为2980.96%、413.21%、130.66%，振幅较大的相关个股有Sonnet Biotherapeutics Holdings, Inc.、Cardio Diagnostics Holdings Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为77.67%、75.31%、57.62%。Rezolute, Inc.公司简介：Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107013352971a4d8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107013352971a4d8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RZLT"],"gpt_icon":0},{"id":"2481541559","title":"美国研究综述-信诺、万豪、拉尔夫-劳伦","url":"https://stock-news.laohu8.com/highlight/detail?id=2481541559","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481541559?lang=zh_cn&edition=full","pubTime":"2024-11-05 15:04","pubTimestamp":1730790257,"startTime":"0","endTime":"0","summary":"    路透11月5日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Cigna、万豪和 Ralph Lauren。要闻             * Cigna   ：Piper Sandler将目标价从392美元上调至394美元             * 万豪  ：杰富瑞将目标价从 225 美元上调至 251 美元              * Ralph Lauren Corp   ：TD Cowen 将目标价从 208 美元上调至 251 美元              * Vertex Pharmaceuticals Inc   ：丰业银行将目标价从480美元上调至486美元             * Wynn Resorts Ltd   ：摩根大通将目标价从101美元上调至113美元  以下是路透周二报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1244550221.USD","LU0266512127.USD","BMRN","MAR","INSP","PTGX","SM","FOXA","CAMP","LU0320765489.SGD","GKOS","ILMN","BK4106","AMG","LU0949170772.SGD","FIS","CSTL","CI","SLAB","NYT","BWIN","ARES","FRPT","EDIT","OMI","RL","LU0971096721.USD","LU1363072403.SGD","LSCC","ST","MDGL","IE00BZ1G4Q59.USD","CMS","HIMS","SHAK","AWI","BEN","RZLT","NMRA","EVER","LU1489326972.SGD","LU","LU0149725797.USD","ATUS","IRON","EGHT","KROS"],"gpt_icon":1},{"id":"2481415545","title":"美国研究综述-信诺、万豪、拉尔夫-劳伦","url":"https://stock-news.laohu8.com/highlight/detail?id=2481415545","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481415545?lang=zh_cn&edition=full","pubTime":"2024-11-05 15:04","pubTimestamp":1730790257,"startTime":"0","endTime":"0","summary":"    路透11月5日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Cigna、万豪和 Ralph Lauren。要闻             * Cigna   ：Piper Sandler将目标价从392美元上调至394美元             * 万豪  ：杰富瑞将目标价从 225 美元上调至 251 美元              * Ralph Lauren Corp   ：TD Cowen 将目标价从 208 美元上调至 251 美元              * Vertex Pharmaceuticals Inc   ：丰业银行将目标价从480美元上调至486美元             * Wynn Resorts Ltd   ：摩根大通将目标价从101美元上调至113美元  以下是路透周二报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LSCC","IRON","CSTL","KROS","EGHT","FOXA","MAR","AWI","LU0266512127.USD","BK4106","CAMP","LU0949170772.SGD","LU","BEN","BMRN","LU0971096721.USD","RZLT","PTGX","EVER","IE00BZ1G4Q59.USD","SLAB","GKOS","AMG","ARES","FIS","ST","MDGL","LU1244550221.USD","NMRA","EDIT","SM","CI","INSP","LU1489326972.SGD","NYT","LU0320765489.SGD","ATUS","BWIN","ILMN","SHAK","LU1363072403.SGD","CMS","FRPT","LU0149725797.USD","RL","OMI"],"gpt_icon":1},{"id":"2478391259","title":"Rezolute, Inc.盘中异动 快速拉升5.23%报5.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478391259","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478391259?lang=zh_cn&edition=full","pubTime":"2024-10-25 21:38","pubTimestamp":1729863490,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日21时38分，Rezolute, Inc.股票出现异动，股价大幅拉升5.23%。截至发稿，该股报5.83美元/股，成交量5.2297万股，换手率0.09%，振幅2.42%。Rezolute, Inc.股票所在的生物技术行业中，整体涨幅为0.66%。其相关个股中，Elevai Labs, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Immunitybio, Inc.涨幅较大，180 Life Sciences Corp.、Elevai Labs, Inc.、Monopar Therapeutics Inc.较为活跃，换手率分别为513.88%、423.42%、27.37%，振幅较大的相关个股有Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Elevai Labs, Inc.、180 Life Sciences Corp.，振幅分别为77.79%、52.82%、35.31%。Rezolute, Inc.公司简介：Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025213811a1ea8402&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025213811a1ea8402&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"2477436643","title":"Rezolute, Inc.盘中异动 股价大涨5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477436643","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477436643?lang=zh_cn&edition=full","pubTime":"2024-10-23 01:36","pubTimestamp":1729618618,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日01时36分，Rezolute, Inc.股票出现异动，股价急速拉升5.32%。截至发稿，该股报5.15美元/股，成交量80.9519万股，换手率1.46%，振幅5.32%。Rezolute, Inc.股票所在的生物技术行业中，整体跌幅为1.14%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Genprex, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为5403.61%、4904.19%、2103.97%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Genprex, Inc.、Aptevo Therapeutics Inc.，振幅分别为189.27%、101.99%、99.41%。Rezolute, Inc.公司简介：Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023013659ab6c46a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023013659ab6c46a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"1154934630","title":"这9只生物科技股今年已暴涨翻倍，分析师预测未来还有翻倍空间！","url":"https://stock-news.laohu8.com/highlight/detail?id=1154934630","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154934630?lang=zh_cn&edition=full","pubTime":"2024-10-17 13:46","pubTimestamp":1729143997,"startTime":"0","endTime":"0","summary":"9只医疗保健股票今年股价已经翻倍，根据分析师的预测，这9只股票未来仍有超过100%的上涨潜力。生物科技行业的股票通常被分析师视为比其他行业的投资风险更高。根据五位分析师的目标价中值，预计 Benitec 未来 12 个月将上涨 104%。Praxis今年迄今已上涨223%，跟踪该股票的10位分析师预计未来12个月将上涨103%。Humacyte今年已翻倍，分析师预计它在未来12个月内还将再次翻倍。","market":"us","thumbnail":"https://community-static.tradeup.com/news/ae91103f9636ad1491772cb329b87218","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/ae91103f9636ad1491772cb329b87218"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"这9只生物科技股今年已暴涨翻倍，分析师预测未来还有翻倍空间！","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRVI","PRAX","ARQT","BNTC","RZLT","CRBP","DCTH","JSPR","HUMA"],"gpt_icon":1},{"id":"2475990451","title":"Rezolute, Inc.盘中异动 快速上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475990451","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475990451?lang=zh_cn&edition=full","pubTime":"2024-10-16 21:37","pubTimestamp":1729085877,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日21时37分，Rezolute, Inc.股票出现异动，股价快速上涨5.08%。截至发稿，该股报5.07美元/股，成交量1.5478万股，换手率0.03%，振幅4.15%。Rezolute, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025、Biodexa Pharmaceuticals Plc涨幅较大，180 Life Sciences Corp.、Biodexa Pharmaceuticals Plc、Gri Bio, Inc.较为活跃，换手率分别为3627.02%、815.04%、140.06%，振幅较大的相关个股有180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为409.87%、192.77%、121.40%。Rezolute, Inc.公司简介：Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016213757ab6a8e91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016213757ab6a8e91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"2472861444","title":"Rezolute, Inc.盘中异动 早盘急速上涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472861444","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472861444?lang=zh_cn&edition=full","pubTime":"2024-10-03 22:33","pubTimestamp":1727966021,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日22时33分，Rezolute, Inc.股票出现波动，股价快速上涨5.31%。截至发稿，该股报4.96美元/股，成交量4.6184万股，换手率0.08%，振幅4.67%。Rezolute, Inc.股票所在的生物技术行业中，整体跌幅为0.82%。其相关个股中，Elevai Labs, Inc.、Theriva Biologics, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Theriva Biologics, Inc.、Aditxt, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为4270.00%、1035.15%、787.77%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Elevai Labs, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为142.28%、59.86%、43.48%。Rezolute, Inc.公司简介：Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003223342a1de2782&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003223342a1de2782&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RZLT"],"gpt_icon":0},{"id":"2472637513","title":"Rezolute, Inc.盘中异动 早盘股价大跌5.15%报4.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472637513","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472637513?lang=zh_cn&edition=full","pubTime":"2024-10-01 21:45","pubTimestamp":1727790329,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日21时45分，Rezolute, Inc.股票出现异动，股价急速跳水5.15%。截至发稿，该股报4.60美元/股，成交量3.2702万股，换手率0.06%，振幅4.02%。Rezolute, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Aditxt, Inc.、Silexion Therapeutics Corp、Sagimet Biosciences Inc. - Series A较为活跃，换手率分别为563.44%、490.15%、77.13%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Briacell Therapeutics Corp.、Bioatla, Inc.，振幅分别为82.42%、30.65%、28.98%。Rezolute, Inc.公司简介：Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001214529a1dddcaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001214529a1dddcaf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"2469273851","title":"Rezolute, Inc.盘中异动 股价大跌5.12%报4.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469273851","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469273851?lang=zh_cn&edition=full","pubTime":"2024-09-24 03:55","pubTimestamp":1727121305,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日03时55分，Rezolute, Inc.股票出现波动，股价快速下跌5.12%。截至发稿，该股报4.82美元/股，成交量20.4884万股，换手率0.37%，振幅5.41%。Rezolute, Inc.股票所在的生物技术行业中，整体跌幅为2.57%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Tc Biopharm  Plc C/Wts 10/02/2028 、Serina Therapeutics, Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Elevai Labs, Inc.、Novabay Pharmaceuticals, Inc.较为活跃，换手率分别为347.13%、107.08%、82.96%，振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Serina Therapeutics, Inc.，振幅分别为74.90%、57.08%、50.30%。Rezolute, Inc.公司简介：Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924035505a1dbf75b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924035505a1dbf75b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RZLT"],"gpt_icon":0},{"id":"2469534984","title":"Rezolute, Inc.2024财年实现净利润-68.46百万美元，同比减少32.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469534984","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469534984?lang=zh_cn&edition=full","pubTime":"2024-09-21 09:00","pubTimestamp":1726880413,"startTime":"0","endTime":"0","summary":"9月21日，Rezolute, Inc.公布财报，公告显示公司2024财年净利润为-68.46百万美元，同比减少32.19%；其中营业收入为0.00美元，每股基本收益为-1.33美元。从资产负债表来看，Rezolute, Inc.总负债11.73百万美元，其中短期债务568000.00美元，资产负债比为0.12，流动比率为0.14。机构评级：截至2024年9月21日，当前有8家机构对Rezolute, Inc.目标价做出预测，其中目标均价为12.75美元，其中最低目标价为7.00美元，最高目标价为15.00美元。其管道产品包括RZ358和RZ402。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409210900159572caf3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409210900159572caf3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT"],"gpt_icon":0},{"id":"2468077615","title":"Rezolute, Inc.盘中异动 快速上涨5.13%报5.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468077615","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468077615?lang=zh_cn&edition=full","pubTime":"2024-09-20 00:37","pubTimestamp":1726763841,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日00时37分，Rezolute, Inc.股票出现波动，股价大幅拉升5.13%。截至发稿，该股报5.12美元/股，成交量31.0325万股，换手率0.56%，振幅8.01%。Rezolute, Inc.股票所在的生物技术行业中，整体涨幅为1.64%。其相关个股中，Exicure, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Edgewise Therapeutics, Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Portage Biotech Inc.较为活跃，换手率分别为4728.09%、888.25%、205.84%，振幅较大的相关个股有Exicure, Inc.、Galmed Pharmaceuticals Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为101.31%、78.69%、52.97%。Rezolute, Inc.公司简介：Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920003721ab64a895&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920003721ab64a895&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"2466510787","title":"美国研究综述-苹果、联邦快递、Vaxcyte","url":"https://stock-news.laohu8.com/highlight/detail?id=2466510787","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466510787?lang=zh_cn&edition=full","pubTime":"2024-09-10 15:37","pubTimestamp":1725953827,"startTime":"0","endTime":"0","summary":"    路透9月10日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Exlservice Apple、Fedex 和 Vaxcyte。* Fedex Corp   ：Stephens 将目标价从 360 美元下调至 350 美元             * Spire Global Inc   ：Canaccord Genuity恢复买入评级             * Vaxcyte Inc   ：瑞穗将目标价从 113 美元上调至 163 美元以下是路透周二报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SHLS","IE00B19Z8X17.USD","APP","BK4581","CDMO","LU1803068979.SGD","MEI","PCVX","TRGP","TVTX","IE00BKVL7J92.USD","CUBE","PNC","BK4505","IE00B19Z8W00.USD","TERN","BK4573","BK4504","LU0158827781.USD","LU0170899867.USD","LU0323591593.USD","PSA","RZLT","LU0109392836.USD","RLAY","LU0719512351.SGD","BOOT","AAPL","MCFT","EL","BK4503","DK","INSP","FDX","EXR","IE00BJJMRY28.SGD","BK4574","LU0198837287.USD","SPIR","BK4527","BK4084","LU0742534661.SGD","IE0004091025.USD","LU0320765489.SGD","BK4170","RBRK","BK4183","LU0861579265.USD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.rezolutebio.com","stockEarnings":[{"period":"1week","weight":0.1298},{"period":"1month","weight":-0.006},{"period":"3month","weight":-0.004},{"period":"6month","weight":0.1535},{"period":"1year","weight":4.0162},{"period":"ytd","weight":3.9975}],"compareEarnings":[{"period":"1week","weight":0.0065},{"period":"1month","weight":-0.0064},{"period":"3month","weight":0.0412},{"period":"6month","weight":0.0933},{"period":"1year","weight":0.2482},{"period":"ytd","weight":0.2518}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Rezolute, Inc.于2010年在特拉华州注册成立，并于2021年6月在内华达州重新注册成立。该公司是一家临床阶段的生物制药公司，开发与慢性葡萄糖失衡相关的代谢疾病的疗法。该公司的主要临床资产RZ358是一种治疗先天性高胰岛素血症的潜在药物，这是一种极其罕见的儿科遗传性疾病，其特征是胰腺产生过多的胰岛素。","yearOnYearQuotes":[{"month":1,"riseRate":0.833333,"avgChangeRate":0.418523},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.05511},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.056507},{"month":4,"riseRate":0.666667,"avgChangeRate":0.028295},{"month":5,"riseRate":0.428571,"avgChangeRate":0.047485},{"month":6,"riseRate":0.714286,"avgChangeRate":0.175136},{"month":7,"riseRate":0.428571,"avgChangeRate":0.339568},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.040809},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.075025},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.179999},{"month":11,"riseRate":0.142857,"avgChangeRate":0.02482},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.118586}],"exchange":"NASDAQ","name":"Rezolute, Inc.","nameEN":"Rezolute, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Rezolute, Inc.(RZLT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Rezolute, Inc.(RZLT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Rezolute, Inc.,RZLT,Rezolute, Inc.股票,Rezolute, Inc.股票老虎,Rezolute, Inc.股票老虎国际,Rezolute, Inc.行情,Rezolute, Inc.股票行情,Rezolute, Inc.股价,Rezolute, Inc.股市,Rezolute, Inc.股票价格,Rezolute, Inc.股票交易,Rezolute, Inc.股票购买,Rezolute, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Rezolute, Inc.(RZLT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Rezolute, Inc.(RZLT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}